Investors

MD Medical Group Today

Investment Case

One of the largest private healthcare providers in Russia

Leading company focusing on women’s and children’s healthcare

A unique combination of a broad scope of medical expertise, extensive geography and varied formats of medical assistance services

The first public company in the industry, with the London Stock Exchange IPO back in 2012

Primary listing of GDRs on the Moscow Exchange (ticker: MDMG)

Revenue Rub27.6 bn for 2023

EBITDA Rub9.2 bn for 2023

Profit up to 100% may be allocated to dividends

Net cash position Rub9 bn as at 31.12.2023

	2023	2022	2021	2020	2019
Revenue, Rub mln	27,631	25,222	25,220	19,133	16,160
EBITDA, Rub mln	9,218	7,924	8,276	6,008	4,635
EBITDA margin, %	33	31	33	31	29
Net profit, Rub mln	7,823	6,005*	6,143	4,333	2,787
Net margin, %	28	24	24	23	17
CAPEX, Rub mln	3,580	1,169	3,790	3,904	3,992
Net debt/EBITDA	-1.0x	-0.5x	0.2x	0.5x	0.8x

Annual reports

MD Medical Group Annual Report

PDF 2023

MD Medical Group Annual Report

PDF 2022

MD Medical Group Annual Report

PDF 2021

Share capital structure

Financial results

1Q 2024 Operating Results

PDF 0.3 Mb

FY2023 Financial Results

PDF 409 Kb

3Q 2023 Operating Results

PDF 494 Κb

MD Medical adheres to the highest standards of corporate governance. The Company has an effective system of corporate governance and internal control of financial and economic activities that complies with Russian legislation, the rules of the Moscow Exchange, and the best international practices.

Continuous improvement of the corporate governance system is one of the main long-term strategic priorities of the Company.